SOCS2 and ductal breast carcinoma in situ: SOCS-2 gene expression more significantly increased in the cancerous cells (+135% vs normal duct, P<0.05) of in situ ductal carcinoma, as well as in the tumoral area of infiltrating carcinoma (+50% vs normal duct, P<0.05) (Figure 3B).